null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Ladiratuzumab Biosimilar (Anti-LIV-1) Antibody (HDBS0112)

SKU HDBS0112
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein LIV-1
Reactivity Human
Host Species Humanized
Isotype IgG1
€431
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Ladiratuzumab (Anti-LIV-1) Biosimilar Antibody (HDBS0112)

The Ladiratuzumab Biosimilar Anti-LIV-1 Antibody is a cutting-edge research tool for studying the LIV-1 protein, a key player in breast cancer progression and metastasis. This monoclonal antibody, engineered for high specificity and sensitivity, is ideal for use in various immunoassays and immunohistochemistry applications.LIV-1, a transmembrane protein overexpressed in breast cancer cells, is associated with tumor growth, invasion, and resistance to chemotherapy. Targeting LIV-1 with antibodies like ladiratuzumab has shown promise in inhibiting tumor progression and improving treatment outcomes in preclinical studies.

Researchers in the fields of oncology, molecular biology, and immuno-oncology will benefit from the exceptional performance of this biosimilar antibody in their investigations of LIV-1's role in breast cancer development and potential therapeutic interventions. Stay ahead in cancer research with the ladiratuzumab biosimilar anti-LIV-1 antibody from Assay Genie.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose